Do Orthotopic Ileal Diversions Induce Immunological Changes in Retained Urethral Tissue

作者: Günter Niegisch , Christina Hulsbergen - van de Kaa , Martine Ploeg , Kees Hendricksen , J. Alfred Witjes

DOI: 10.3233/BLC-140001

关键词:

摘要: Background A second primary tumors of the urethra (urethral recurrence) after radical cystectomy has been reported to be more infrequent in patients with ileal orthotopic (neobladder) compared incontinent diversions. Objective To investigate whether an altered immunogenic environment urethral tissue is induced by urethro-ileal anastomosis. Methods Between 10/2008 and 12/2009 biopsies 19 (9 neobladder patients, 10 control without urethra-ileal anastomosis) were evaluated conventional histopathological examination immunohistochemistry for T- (CD3/CD5, CD4, CD8) B-cell markers (CD20/22, CD79a, CD138). After semi-quantitative assessment, relative cell fractions (B vs. T cells) subclasses (T4-helper T8-killer cells B clones, plasma studied. Unpaired t-test was used statistical analysis. Results Of included 16 eligible analysis (7x neobladder, 9x controls). All had undergone UBC. Comparing positive NB CO no differences observed. In 4/7 fraction CD79a B-cells higher than CD3/CD5 T-cells (B/T-ratio 1.3). predominantly CD138 (5/7 patients). Relative lower T-cell 7/9 0.6). Neither CD 138 nor CD22 clones predominant. T-helper CD8 T-killer equally distributed both (CD4/CD8-ratio: 2.1) 1.9). Conclusions neobadder distribution B- statistically not different. However, a trend towards increased presence tissues that could become relevant larger study might suggestive immunological response connecting tissue.

参考文章(28)
Gil Redelman-Sidi, Michael S. Glickman, Bernard H. Bochner, The mechanism of action of BCG therapy for bladder cancer—a current perspective Nature Reviews Urology. ,vol. 11, pp. 153- 162 ,(2014) , 10.1038/NRUROL.2014.15
J. MATTHEW HASSAN, MICHAEL S. COOKSON, JOSEPH A. SMITH, SAM S. CHANG, URETHRAL RECURRENCE IN PATIENTS FOLLOWING ORTHOTOPIC URINARY DIVERSION The Journal of Urology. ,vol. 172, pp. 1338- 1341 ,(2004) , 10.1097/01.JU.0000138616.05218.21
Shin-ichi Honda, Yoshiro Sakamoto, Makoto Fujime, Ryuichi Kitagawa, Immunohistochemical Study of Tumor-Infiltrating Lymphocytes Before and After Intravesical Bacillus Calmette-Guérin Treatment for Superficial Bladder Cancer International Journal of Urology. ,vol. 4, pp. 68- 73 ,(1997) , 10.1111/J.1442-2042.1997.TB00143.X
Kristian Krpina, Emina Babarović, Gordana Đorđević, Željko Fučkar, Nives Jonjić, The association between the recurrence of solitary non-muscle invasive bladder cancer and tumor infiltrating lymphocytes. Croatian Medical Journal. ,vol. 53, pp. 598- 604 ,(2012) , 10.3325/CMJ.2012.53.598
Phillip K Darcy, Paul Neeson, Carmen SM Yong, Michael H Kershaw, Manipulating immune cells for adoptive immunotherapy of cancer. Current Opinion in Immunology. ,vol. 27, pp. 46- 52 ,(2014) , 10.1016/J.COI.2014.01.008
R. W. Byard, S. Ahmed, G. E. Phillips, P. A. Dewan, Further observations on histological changes at the ureteroileal junction in ileal conduits. Pediatric Surgery International. ,vol. 12, pp. 397- 400 ,(1997) , 10.1007/BF01076949
P.K. Lipponen, M.J. Eskelinen, K. Jauhiainen, E. Harju, R. Terho, Tumour infiltrating lymphocytes as an independent prognostic factor in transitional cell bladder cancer. European Journal of Cancer. ,vol. 29, pp. 69- 75 ,(1993) , 10.1016/0959-8049(93)90579-5
Carlo Fremd, Florian Schuetz, Christof Sohn, Philipp Beckhove, Christoph Domschke, B cell-regulated immune responses in tumor models and cancer patients OncoImmunology. ,vol. 2, ,(2013) , 10.4161/ONCI.25443
JOHN P. STEIN, PETER CLARK, GUS MIRANDA, JIE CAI, SUSAN GROSHEN, DONALD G. SKINNER, URETHRAL TUMOR RECURRENCE FOLLOWING CYSTECTOMY AND URINARY DIVERSION: CLINICAL AND PATHOLOGICAL CHARACTERISTICS IN 768 MALE PATIENTS The Journal of Urology. ,vol. 173, pp. 1163- 1168 ,(1999) , 10.1097/01.JU.0000149679.56884.0F
Z MA Mohammed, J J Going, J Edwards, B Elsberger, J C Doughty, D C McMillan, The relationship between components of tumour inflammatory cell infiltrate and clinicopathological factors and survival in patients with primary operable invasive ductal breast cancer British Journal of Cancer. ,vol. 107, pp. 864- 873 ,(2012) , 10.1038/BJC.2012.347